At Worldwide Clinical Trials, our 1,600+ employees are among the best in their fields – clinicians, scientists, project managers, research specialists, medical experts, and more. Our sponsors across all therapeutic areas benefit from the deep and broad experience of our people in both drug discovery and drug development environments. We partner with our sponsors to help facilitate transitions between medical discovery research and clinical development, bringing better products to market and helping to improve patient lives with enhanced value. We do this through operational acumen, savvy decision-making, deft management and commercial intelligence. This is because you not only need a successfully completed clinical study, you need a study that will help you determine the potential challenges and promise of the drug or device you’re developing as you prepare for market authorization and commercialization.
Clinical development and research in Oncology is intricate, challenging and requires laser focus on managing both science and medicine to deliver results. At Worldwide Clinical Trials, our scientific and medical experts seek the best scientific approaches and apply them with rigorous methodology. By partnering closely with our sponsors, our clinical development plans are as personalized and precise as the drugs being tested. The challenges specific to your trial are anticipated, explored, and solved.
Global Reach and Expertise
We have operational capabilities around the globe, including in countries where centralized healthcare systems promote efficiencies with large referral networks. Culturally and linguistically astute, our staff is intimately familiar with local standards of care and the regional variation in oncology practice that can affect a site’s suitability for a proposed program.
Since 2008, more than 80 oncology studies have been conducted under our project management and monitoring, and Worldwide Clinical Trials also participated in the design, execution, or analysis.
Solid Tumor Malignancies
- Head and neck
- Small intestine
- Mixed Solid Tumors
- Multiple myeloma and malignant plasma cell neoplasms
- Myelodysplastic syndromes
- Non-Hodgkin’s lymphoma
- Acute myeloid leukemia
At Worldwide Clinical Trials, our experts understand that the commercial viability of therapeutics for chronic respiratory disorders is influenced by a range of factors, including perceived value and therapeutic novelty. This has particular relevance to illnesses with established pharmacotherapy such as asthma and COPD. Worldwide Clinical Trails’ philosophy of employing expert clinical trial methodology, combined with our commitment to innovation, helps us deliver data relevant to multiple stakeholder perspectives and appropriate to each phase of your drug or device development.
Relationships and Experience
Our close relationships with opinion leaders and practitioners in respiratory medicine ensure that complex study objectives and eligibility criteria evolve into a plan that delivers reliable metrics, consistently met timelines, and impeccable data. Our team has success in overcoming the unique challenges in conducting trials in respiratory disorders, including for example, determining the allergic status of patients with asthma and managing co-morbidity often associated with COPD.
Worldwide has completed more than 100 studies related to respiratory disorders since 2008. For these studies, Worldwide Clinical Trials provided multiple services, including clinical monitoring or project management services across all phases.
We have completed trials with a wide range of therapeutic interventions, such as corticosteroids, bronchodilators, and antibiotics, as well as kinase inhibitors. Our respiratory disorder experience includes:
- Cystic Fibrosis
- IPF (Idiopathic Pulmonary Fibrosis)
- URTI (Upper Respiratory Tract Infections)
- Perennial and seasonal rhinitis
- Pneumonia (hospital and community acquired)